Literature DB >> 24655099

Simultaneous subependymomas in monozygotic female twins: further evidence for a common genetic or developmental disorder background.

Susan Noell1, Rudi Beschorner, Sotirios Bisdas, Ulrike Beyer, Ruthild G Weber, Petra Fallier-Becker, Rainer Ritz.   

Abstract

In this paper, a rare case of subependymoma of the fourth ventricle in identical female twins is reported. Magnetic resonance imaging and CT showed nearly identical locations of the tumors in the fourth ventricle and similar growth patterns of the tumors in both sisters. Likewise, postoperative histopathological analysis of both tumors revealed the typical histological appearance of subependymomas. Subependymoma is a rare, low-grade glioma of the CNS, slowly growing and usually asymptomatic. If symptomatic, a subependymoma can in some cases lead to sudden death caused by pressure on the brainstem or decompensated secondary hydrocephalus. This case demonstrates the importance of detecting tumors early and thereby preventing symptoms arising from increasing intracranial pressure, and optimizing therapy options.

Entities:  

Keywords:  GFAP = glial fibrillary acidic protein; SNP = single nucleotide polymorphism; familial tumor; fourth ventricle; genetics; monozygotic twins; oncology; subependymoma

Mesh:

Year:  2014        PMID: 24655099     DOI: 10.3171/2014.2.JNS122179

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  2 in total

1.  Bilateral lateral ventricular subependymoma with extensive multiplicity presenting with hemorrhage.

Authors:  F M Moinuddin; Novita Ikbar Khairunnisa; Hirofumi Hirano; Tomoko Hanada; Tsubasa Hiraki; Mari Kirishima; Kiyohisa Kamimura; Kazunori Arita
Journal:  Neuroradiol J       Date:  2017-07-11

2.  TRPS1 gene alterations in human subependymoma.

Authors:  Sascha B Fischer; Michelle Attenhofer; Sakir H Gultekin; Donald A Ross; Karl Heinimann
Journal:  J Neurooncol       Date:  2017-05-20       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.